PARPi: Management of Adverse Events (2024)

CME Available: https://auau.auanet.org/node/39609
Release Date: January, 2024
Expiration Date: January, 2025

LEARNING OBJECTIVES:
1. Identify approved PARPi for prostate cancer and patients who may benefit from PARPi based therapy.
2. Evaluate available clinical safety and efficacy data for PARPi.
3. Describe indications and contraindications for PARPi in patients with advanced prostate cancer.
4. Identify how to manage adverse events that patients may experience while taking a PARPi.

ACKNOWLEDGEMENTS:
This educational activity is supported by an independent educational grant from:
Pfizer, Inc.